WO1994005267A3 - Use of carrageenans as growth factor antagonists - Google Patents
Use of carrageenans as growth factor antagonists Download PDFInfo
- Publication number
- WO1994005267A3 WO1994005267A3 PCT/GB1993/001848 GB9301848W WO9405267A3 WO 1994005267 A3 WO1994005267 A3 WO 1994005267A3 GB 9301848 W GB9301848 W GB 9301848W WO 9405267 A3 WO9405267 A3 WO 9405267A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- growth factor
- carrageenans
- factor antagonists
- useful
- disclosed
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU49726/93A AU4972693A (en) | 1992-09-01 | 1993-09-01 | Use of carrageenans as growth factor antagonists |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929218510A GB9218510D0 (en) | 1992-09-01 | 1992-09-01 | Improvements in or relating to hormone antagonists |
GB9218510.7 | 1992-09-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1994005267A2 WO1994005267A2 (en) | 1994-03-17 |
WO1994005267A3 true WO1994005267A3 (en) | 1994-04-28 |
Family
ID=10721240
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1993/001848 WO1994005267A2 (en) | 1992-09-01 | 1993-09-01 | Use of carrageenans as growth factor antagonists |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU4972693A (en) |
GB (1) | GB9218510D0 (en) |
WO (1) | WO1994005267A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5968551A (en) | 1991-12-24 | 1999-10-19 | Purdue Pharma L.P. | Orally administrable opioid formulations having extended duration of effect |
FR2808687B1 (en) * | 2000-04-27 | 2003-12-05 | Goemar Lab Sa | MEDICAMENT CONTAINING POLYSACCHARIDE SUBSTANCES FOR THE ACTIVATION OF APOPTOSIS |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988006396A2 (en) * | 1987-02-25 | 1988-09-07 | Michael Neushul | Method for the treatment of aids virus and other retroviruses |
-
1992
- 1992-09-01 GB GB929218510A patent/GB9218510D0/en active Pending
-
1993
- 1993-09-01 WO PCT/GB1993/001848 patent/WO1994005267A2/en active Application Filing
- 1993-09-01 AU AU49726/93A patent/AU4972693A/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988006396A2 (en) * | 1987-02-25 | 1988-09-07 | Michael Neushul | Method for the treatment of aids virus and other retroviruses |
Non-Patent Citations (8)
Title |
---|
CHEMICAL ABSTRACTS, vol. 89, no. 3, 17 July 1978, Columbus, Ohio, US; abstract no. 22078w, R.G.P. PUGH-HUMPHREYS ET AL: "The effect of the macrophage cytotoxic agent iota-carrageenan on the growth of two transplantable murine ascites tumors." * |
CHEMICAL ABSTRACTS, vol. 95, no. 9, 31 August 1981, Columbus, Ohio, US; abstract no. 73721g, E. OHTSUKA: "Activation of cytotoxic macrophages by carrageenan with special reference to iota- carrageenan." * |
D.R. COOMBE ET AL.: "Analysis of the inhibition of tumour metastasis by sulphated polysaccharides.", INT. J. CANCER, vol. 39, no. 1, 1987, pages 82 - 88 * |
H. NODA ET AL: "Antitumor activity of marine algae.", HYDROBIOLOGIA, vol. 204/205, 1990, pages 577 - 584 * |
KEITH, MCBRIDE, STUART, EDS., PROC. EURES SYMP. MACROPHAGE CANCER, 1977, pages 142 - 154 * |
NICHIDAI IGAKU ZASSHI, vol. 40, no. 6, 1981, pages 521 - 528 * |
R. ISHAI-MICHAELI ET AL: "heparanase activity expressed by platelets, neutrophils and lymphoma cells releases active fibroblast growth factor from extracellular matrix.", CELL REGUL., vol. 1, no. 11, 1990, pages 833 - 842 * |
T. MATSUMOTO ET AL.: "Growth inhibition of leukemia L-1210 ascites tumor by combination of carrageenan and mitomycin C in vivo.", J. PHARMACO-BIODYN., vol. 7, no. 7, 1984, pages 465 - 471 * |
Also Published As
Publication number | Publication date |
---|---|
WO1994005267A2 (en) | 1994-03-17 |
AU4972693A (en) | 1994-03-29 |
GB9218510D0 (en) | 1992-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0433842A3 (en) | 1,2,3-triazole derivatives active as inhibitors of the enzyme hmg-coa reductase and pharmaceutical compositions containing them | |
AU4041293A (en) | Phenylderivate as inhibitors of atp citrate lyase | |
AU3102697A (en) | Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase | |
DE59611411D1 (en) | USE OF ALPHA 1L AGONISTS FOR THE TREATMENT OF HARNINE CONTINENCE | |
IL130349A0 (en) | Substituted nitrogen containing heterocycles as inhibitors of P38 protein pinase and pharmaceutical compositions containing the same | |
DE122009000012I1 (en) | Substituted pyrazolylbenzenesulfonamides for the treatment of inflammation. | |
ZA9710245B (en) | Heterocycles as inhibitors of leucocyte adhesion and as VLA-4-antagonists. | |
EP0690457A3 (en) | Polyaniline-containing solution, articles coated therewith, and methods for the preparation of same | |
MY117032A (en) | A novel compound form. | |
AU6157396A (en) | Bis-arylsulfonylaminobenzamide derivatives and the use there of as factor xa inhibitors | |
PL321203A1 (en) | Sulphonamide derivatives as inhibitors of kinurenin 3-hydroxylase, method of obtaining novel sulponamide compounds and drugs containing such compounds | |
EP0529854A3 (en) | Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as hmg-coa reductase inhibitors | |
EP0641209A4 (en) | New 17-ester, amide, and ketone derivatives of 3-oxo-4-azasteroids as 5a-reductase inhibitors. | |
AU7270794A (en) | Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors | |
BG109411A (en) | Method for making hiv-protease inhibitors | |
HUP9901984A3 (en) | Naphthyl acetamides as spla2 inhibitors, use thereof and pharmaceutical compositions containing these compounds | |
IL126683A0 (en) | Pharmaceutical composition and method for the treatment of severe blood loss and for the inhibition or treatment of hemorrhagic shock | |
EP0666849A4 (en) | Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis. | |
AR244941A1 (en) | Compound, composition, procedure and use of an anti microbial product. | |
EP0656069A4 (en) | Inhibitors of cell proliferation, their preparation and use. | |
NO992504D0 (en) | Compositions for the treatment of soil, process for its preparation, and use | |
AU6212398A (en) | 2-amino-substituted pyridines which can be used for the treatment of arteriosclerosis and hyperclipoproteinaemia | |
NO931400D0 (en) | DERIVATIVES OF THE ADIPOGENESE INHIBITOR FACTOR, AND THE PREPARATION AND USE OF THEREOF | |
ZA933151B (en) | Cycloheptimidazole derivatives, method of manufacturing the same and therapeutic agents containing these compounds. | |
WO1994005267A3 (en) | Use of carrageenans as growth factor antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AT AU BB BG BR BY CA CH CZ DE DK ES FI GB HU JP KP KR KZ LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AT AU BB BG BR BY CA CH CZ DE DK ES FI GB HU JP KP KR KZ LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |